Search Results - Taha Azad
- Showing 1 - 12 results of 12
-
1
The Role of YAP and TAZ in Angiogenesis and Vascular Mimicry by Taha Azad, Mina Ghahremani, Xiaolong Yang
Published in Cells (2019-05-01)Get full text
Article -
2
Ultrasensitive detection of vital biomolecules based on a multi-purpose BioMEMS for Point of care testing: digoxin measurement as a case study by Fahimeh Marvi, Kian Jafari, Mahmoud Shahabadi, Maryam Tabarzad, Fatemeh Ghorbani-Bidkorpeh, Taha Azad
Published in Scientific Reports (2024-01-01)Get full text
Article -
3
-
4
Recent progress in combination therapy of oncolytic vaccinia virus by Seyedeh Nasim Mirbahari, Seyedeh Nasim Mirbahari, Miles Da Silva, Miles Da Silva, Abril Ixchel Muñoz Zúñiga, Abril Ixchel Muñoz Zúñiga, Nika Kooshki Zamani, Nika Kooshki Zamani, Gabriel St-Laurent, Gabriel St-Laurent, Mehdi Totonchi, Taha Azad, Taha Azad
Published in Frontiers in Immunology (2024-03-01)Get full text
Article -
5
A High-Throughput NanoBiT-Based Serological Assay Detects SARS-CoV-2 Seroconversion by Taha Azad, Reza Rezaei, Ragunath Singaravelu, Taylor R. Jamieson, Mathieu J. F. Crupi, Abera Surendran, Joanna Poutou, Parisa Taklifi, Juthaporn Cowan, Donald William Cameron, Carolina S. Ilkow
Published in Nanomaterials (2021-03-01)Get full text
Article -
6
Luciferase-Based Biosensors in the Era of the COVID-19 Pandemic by Taha Azad, Helena J. Janse van Rensburg, Jessica Morgan, Reza Rezaei, Mathieu J. F. Crupi, Rui Chen, Mina Ghahremani, Monire Jamalkhah, Nicole Forbes, Carolina Ilkow, John C. Bell
Published in ACS Nanoscience Au (2021-08-01)Get full text
Article -
7
Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy by Nikolas T. Martin, Mathieu J. F. Crupi, Zaid Taha, Joanna Poutou, Jack T. Whelan, Sydney Vallati, Julia Petryk, Ricardo Marius, Bradley Austin, Taha Azad, Mason Boulanger, Tamara Burgess, Ilson Sanders, Camille Victoor, Bryan C. Dickinson, Jean-Simon Diallo, Carolina S. Ilkow, John C. Bell
Published in Pharmaceuticals (2023-05-01)Get full text
Article -
8
A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection by Stephen Boulton, Joanna Poutou, Rida Gill, Nouf Alluqmani, Xiaohong He, Ragunath Singaravelu, Mathieu J.F. Crupi, Julia Petryk, Bradley Austin, Leonard Angka, Zaid Taha, Iris Teo, Siddarth Singh, Rameen Jamil, Ricardo Marius, Nikolas Martin, Taylor Jamieson, Taha Azad, Jean-Simon Diallo, Carolina S. Ilkow, John C. Bell
Published in Molecular Therapy: Methods & Clinical Development (2023-12-01)Get full text
Article -
9
Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization by Taha Azad, Ragunath Singaravelu, Mathieu J.F. Crupi, Taylor Jamieson, Jaahnavi Dave, Emily E.F. Brown, Reza Rezaei, Zaid Taha, Stephen Boulton, Nikolas T. Martin, Abera Surendran, Joanna Poutou, Mina Ghahremani, Kazem Nouri, Jack T. Whelan, Jessie Duong, Sarah Tucker, Jean-Simon Diallo, John C. Bell, Carolina S. Ilkow
Published in Membranes (2020-08-01)Get full text
Article -
10
Fatty acid transport protein inhibition sensitizes breast and ovarian cancers to oncolytic virus therapy via lipid modulation of the tumor microenvironment by Abera Surendran, Abera Surendran, Monire Jamalkhah, Monire Jamalkhah, Joanna Poutou, Rayanna Birtch, Rayanna Birtch, Christine Lawson, Jaahnavi Dave, Jaahnavi Dave, Mathieu J. F. Crupi, Mathieu J. F. Crupi, Justin Mayer, Victoria Taylor, Julia Petryk, Christiano Tanese de Souza, Neil Moodie, Jacob Lecompte Billingsley, Bradley Austin, Nicole Cormack, Natalie Blamey, Reza Rezaei, Reza Rezaei, Curtis W. McCloskey, Curtis W. McCloskey, Emily E. F. Fekete, Emily E. F. Fekete, Harsimrat K. Birdi, Harsimrat K. Birdi, Serge Neault, Serge Neault, Taylor R. Jamieson, Taylor R. Jamieson, Brenna Wylie, Sarah Tucker, Taha Azad, Taha Azad, Barbara Vanderhyden, Barbara Vanderhyden, Lee-Hwa Tai, John C. Bell, John C. Bell, Carolina S. Ilkow, Carolina S. Ilkow
Published in Frontiers in Immunology (2023-03-01)Get full text
Article -
11
CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX by Jack T. Whelan, Jack T. Whelan, Ragunath Singaravelu, Ragunath Singaravelu, Ragunath Singaravelu, Fuan Wang, Fuan Wang, Adrian Pelin, Adrian Pelin, Levi A. Tamming, Levi A. Tamming, Giuseppe Pugliese, Nikolas T. Martin, Nikolas T. Martin, Mathieu J. F. Crupi, Mathieu J. F. Crupi, Julia Petryk, Bradley Austin, Xiaohong He, Ricardo Marius, Ricardo Marius, Jessie Duong, Jessie Duong, Carter Jones, Emily E. F. Fekete, Emily E. F. Fekete, Nouf Alluqmani, Nouf Alluqmani, Andrew Chen, Stephen Boulton, Stephen Boulton, Michael S. Huh, Matt Y. Tang, Zaid Taha, Zaid Taha, Elena Scut, Elena Scut, Jean-Simon Diallo, Jean-Simon Diallo, Taha Azad, Taha Azad, Brian D. Lichty, Brian D. Lichty, Carolina S. Ilkow, Carolina S. Ilkow, John C. Bell, John C. Bell
Published in Frontiers in Immunology (2023-01-01)Get full text
Article -
12
Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies by Taha Azad, Reza Rezaei, Ragunath Singaravelu, Adrian Pelin, Stephen Boulton, Julia Petryk, Kemal Alper Onsu, Nikolas T. Martin, Victoria Hoskin, Mina Ghahremani, Marie Marotel, Ricardo Marius, Xiaohong He, Mathieu J. F. Crupi, Huy-Dung Hoang, Abolfazl Nik-Akhtar, Mahsa Ahmadi, Nika Kooshki Zamani, Ashkan Golshani, Tommy Alain, Peter Greer, Michele Ardolino, Bryan C. Dickinson, Lee-Hwa Tai, Carolina S. Ilkow, John C. Bell
Published in Nature Communications (2023-05-01)Get full text
Article
